Login:
 
Lockyer M. Non invasive skin autofluorescence test shows promise in new onset diabetes and CVD. Practitioner Dec 2018;262(1821):7-10

Non invasive skin autofluorescence test shows promise

20 Dec 2018Registered users

An immunofluorescence test may be able to predict new onset diabetes, cardiovascular disease (CVD) and death, a study from the Netherlands has shown.

Registered usersThis article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.

To buy this article (£25+tax) copy the article citation above and click Buy article